PHARMACEUTICAL COMPOSITIONS OF A KINASE INHIBITOR

The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to...

Full description

Saved in:
Bibliographic Details
Main Authors LIEJANTO, Iswadi, CHEN, Tzu-Yuan
Format Patent
LanguageEnglish
French
Published 12.05.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions. La présente invention concerne des compositions pharmaceutiques de l'Inhibiteur de c-Met, composé 1. L'invention concerne également des méthodes de traitement d'une maladie, d'un trouble ou d'un syndrome médié au moins en partie par la modulation de l'activité in vivo d'une protéine kinase à l'aide de la composition pharmaceutique et des procédés de fabrication des compositions pharmaceutiques.
Bibliography:Application Number: WO2021US57996